Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · IEX Real-Time Price · USD
9.31
-0.25 (-2.62%)
At close: Mar 28, 2024, 4:00 PM
9.21
-0.10 (-1.07%)
After-hours: Mar 28, 2024, 7:36 PM EDT

Voyager Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014
Revenue
250.0140.9137.42171.13104.397.6210.1414.2217.330
Revenue Growth (YoY)
511.16%9.33%-78.14%63.93%1270.14%-24.82%-28.73%-17.96%--
Gross Profit
250.0140.9137.42171.13104.397.6210.1414.2217.330
Selling, General & Admin
35.8230.9837.2534.9936.3433.8119.7413.279.915.47
Research & Development
92.1760.7673.79108.75119.7464.9162.2642.2527.688.9
Operating Expenses
127.9991.74111.03143.74156.0798.718255.5237.5914.37
Operating Income
122.01-50.84-73.6227.38-51.68-91.1-71.86-41.3-20.25-14.37
Interest Expense / Income
-11.72-1.790.39-1.66-6.4600000
Other Expense / Income
-0-2.65-2.81-7.7-1.63-2.63-1.17-1.169.421.95
Pretax Income
133.74-46.39-71.236.74-43.6-88.47-70.7-40.14-29.67-16.32
Income Tax
1.410.02000-0.1800.0500
Net Income
132.33-46.41-71.236.74-43.6-88.29-70.7-40.19-29.67-16.32
Preferred Dividends
000000008.621.37
Net Income Common
132.33-46.41-71.236.74-43.6-88.29-70.7-40.19-38.29-17.68
Shares Outstanding (Basic)
433838373632272541
Shares Outstanding (Diluted)
453838373632272541
Shares Change
16.20%1.83%0.86%4.04%11.95%19.63%5.93%503.70%559.57%-
EPS (Basic)
3.08-1.21-1.890.99-1.21-2.75-2.64-1.59-9.14-27.83
EPS (Diluted)
2.97-1.21-1.890.98-1.21-2.75-2.64-1.59-9.14-27.83
Free Cash Flow
74.66-15-55.13-108.8141.12-20.19-65.34-47.5140.27-14.91
Free Cash Flow Per Share
1.74-0.39-1.46-2.931.15-0.63-2.44-1.889.61-23.46
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%-
Operating Margin
48.80%-124.27%-196.76%16.00%-49.51%-1195.63%-709.06%-290.43%-116.85%-
Profit Margin
52.93%-113.45%-190.29%21.47%-41.76%-1158.79%-697.56%-282.65%-220.90%-
Free Cash Flow Margin
29.86%-36.67%-147.36%-63.59%39.39%-265.02%-644.65%-334.11%232.31%-
Effective Tax Rate
1.05%---------
EBITDA
126.46-41.99-65.6438.9-47.29-86.35-69.1-39.53-29.07-16.13
EBITDA Margin
50.58%-102.65%-175.44%22.73%-45.30%-1133.36%-681.83%-277.98%-167.72%-
Depreciation & Amortization
4.446.195.173.822.772.121.60.610.60.18
EBIT
122.02-48.18-70.8135.08-50.05-88.47-70.7-40.14-29.67-16.32
EBIT Margin
48.81%-117.79%-189.25%20.50%-47.95%-1161.15%-697.56%-282.29%-171.18%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).